John Ligon
Assistant Professor · University of Florida
Dr. John Ligon is a translational researcher committed to advancing novel cellular therapies and immunotherapies.
Cancer Cancer Immunotherapy Clinical Trials Developmental Therapeutics Oncology
Qin Wang, PhD
Professor of Neuroscience & Regenerative Medicine · Augusta University
Qin Wang researches the neuropharmacology and signaling mechanisms underlying neurological and psychiatric disorders.
Neurological Disorders Regenerative Medicine Molecular Neuropharmacology Neuroscience Neuropharmacology
Philip Santangelo
Professor, Biomedical Engineering · Georgia Tech - COE
Philip J. Santangelo researches optical microscopy and in vivo imaging, RNA virus pathogenesis, HIV/SIV.
Therapeutics and Vaccines RNA Regulation RNA Virus Pathogenesis Optical Microscopy and In Vivo Imaging HIV/SIV and hRSV
Lisa Holle, Pharm.D., BCOP, FHOPA
Associate Clinical Professor of Pharmacy Practice · University of Connecticut
Dr. Holle’s clinical research focuses on medical marijuana, oral cancer therapy management, and impact of clinical pharmacy services
MyDispense Medical Marijuana Pain Cancer Cancer Therapeutics
Norbert Kaminski
Professor of Toxicology, Director of the Institute for Integrative Toxicology · Michigan State University
Expert on cannabinoid research and toxicology.
Experimental therapeutics Cannabinoids Toxicology Immunotoxicology
Locke Bryan, PhD
Medical Hematologist-Oncologist · Georgia Cancer Center at Augusta University
A leading medical hematologist-oncologist who also specializes in Lymphomas Immunotherapy Novel Therapeutics.
Lymphomas Immunotherapy Novel Therapeutics Cancer
Michael H. Peters, Ph.D.
Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering
Professor Peters conducts experimental and theoretical research in the field of protein engineering.
Peptidyl-Biomimetics Inhibitors for Breast Cancer Targets OpenContact: A Simple Static Protein-Protein Mapping Algorithm Extended Liouville Equation for Open Systems Neuronal Stem Cell Delivery Systems Protein Engineering
Elisabeth Barton
Professor/Associate Dean · University of Florida
Elisabeth Barton is a molecular physiologist with a primary interest in skeletal muscle repair.
Space Viral Gene Therapy Optimization of IGF-I for Muscle Therapeutics Mechanical Signal Transduction Skeletal Muscle Repair
Gerry Brunk
Managing Director · Lumira Ventures
Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.
Business Strategy Medical Devices Pharmaceutical Industry Drug Development Commercialization
Bruce Armitage
Professor and Co-Director · Carnegie Mellon University
Bruce Armitage’s current research interests include the use of PNA for sequence-specific recognition of DNA and RNA.
Peptide Nucleic Acids DNA Nanotechnology Bioorganic Chemistry Fluorescent Dyes Molecular Evolution
John McCulloch
Founder & Managing Director · Burloch Group Inc.
Engaging and knowledgeable speaker with deep expertise in biotechnology investment.
Biotechnology Pharmaceuticals Innovation Investment
Robert Lanza
Scientist · Ocata Therapeutics
Robert Lanza is currently Chief Scientific Officer at Ocata Therapeutics and Adjunct Professor at Wake Forest University School of Medicine.
biocentrism Science Research Regenerative Medicine
Riccardo Panicucci
Senior VP CMC · QED Therapeutics and Origin Biosciences
Riccardo Panicucci is an expert in the pharmaceutical industry, biotechnology, clinical development, and biopharmaceuticals.
Technology Transfer Biotechnology Clinical Development Drug Discovery Drug Development
Dr. Mark Ware
Chief Medical Officer · Canopy Growth
Dr. Ware leads Canopy Growth’s medical division, Spectrum Therapeutics including research towards the development of cannabinoid medicines.
Endocannabinoid System Cannabis Research Cannabinoids Medical Cannabis Clinical Research
Emily Walsh
Principal Consultant · Halloran Consulting Group, Inc.
Recovering Scientist
Personalized Medicine and Genetics Translational Medicine Transitioning From the Bench Project Management 101 Program Management 101
Avak Kahvejian
Partner, VentureLabs · Flagship Pioneering
Avak Kahvejian is an expert in conceiving and launching internally generated platform companies and leveraging new biological mechanisms.
Biotechnologies Design Biology Technology Biological Mechanisms
Paulina Hill
Principal · Omega Funds
Paulina Hill is a healthcare investor who has expertise in biotechnology, molecular biology, cell culture and entrepreneurship.
Venture Capital Chemistry Technology Transfer Biochemistry Lifesciences
Andrew Lover
Associate Professor of Epidemiology and Deputy Director, New England Center of Excellence in Vector-Borne Disease · University of Massachusetts Amherst
Andrew Lover is an infectious disease epidemiologist whose work focuses on malaria and other vector-borne diseases.
Tick-borne Diseases Infectious Disease Vector-Borne Diseases Drug Development Malaria
Robert Kemp
VP of Market Access and HEOR · Breath Therapeutics
Robert Kemp is an expert at developing value strategies using clinical and economic information.
Health Plans Health Informatics Medical Device Outcomes Research Strategic Leadership
Gordon Mitchell
Professor & Director · University of Florida
Gordon Mitchell is a preeminence professor of neuroscience in the department of physical therapy and McKnight Brain Institute.
Cellular mechanisms of intermittent hypoxia induced spinal respiratory motor plasticity Compensatory respiratory plasticity in motor neuron disease (ALS) Inflammation and spinal plasticity Developmental plasticity Intermittent hypoxia and brain function